Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Insulin sensitizer induces ovulation in women with PCOS

June 17, 1998

Beta3-adrenoceptor agonist CL-316243 enhances insulin activity in humans

June 17, 1998

Tetrahydrobenzo[a]fluorenes for postmenopausal symptoms and related disorders

June 17, 1998

Insulin sensitizers developed at JT with potent hypoglycemic effects

June 17, 1998

PTPase active-site modulators from Ontogen: a novel approach to treating diabetes

June 17, 1998

SDZ-WAG-994 useful for cardiovascular/metabolic complications in diabetes

June 17, 1998

TH-9506 achieves positive phase I results

June 16, 1998

DiavaX potential for vaccination against diabetes shown in preclinical models

June 16, 1998

Positive FDA preliminary review of Cenestin NDA

June 16, 1998

Alexion presents antidiabetic fusion protein at ADA meeting

June 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...